CN
FDA's New CCS Draft Explicitly Encourages Deterministic CCIT—While Keeping Method Selection Risk-Based
FDA’s August 13, 2026 draft guidance, Container Closure Systems for Human Drugs and Biological Products, is the agency’s most substantial refresh of its umbrella CCS guidance since 1999.
2026.08.22
